These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 33963800)
1. Editorial for "Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma". Sivanesan U; van der Pol CB J Magn Reson Imaging; 2021 Nov; 54(5):1444-1445. PubMed ID: 33963800 [No Abstract] [Full Text] [Related]
2. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma. Meng Y; Zhang H; Li Q; Xing P; Liu F; Cao K; Fang X; Li J; Yu J; Feng X; Ma C; Wang L; Jiang H; Lu J; Bian Y; Shao C J Magn Reson Imaging; 2021 Nov; 54(5):1432-1443. PubMed ID: 33890347 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Tumor-Infiltrating CD20 Li Q; Yu J; Zhang H; Meng Y; Liu YF; Jiang H; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Feng X; Lu J; Shao C; Bian Y Acad Radiol; 2022 Sep; 29(9):e167-e177. PubMed ID: 34922828 [TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting CD20 Yu J; Li Q; Zhang H; Meng Y; Liu YF; Jiang H; Ma C; Liu F; Fang X; Li J; Feng X; Shao C; Bian Y; Lu J Abdom Radiol (NY); 2022 Jan; 47(1):242-253. PubMed ID: 34708252 [TBL] [Abstract][Full Text] [Related]
5. CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging. Zhang Y; Lobo-Mueller EM; Karanicolas P; Gallinger S; Haider MA; Khalvati F BMC Med Imaging; 2020 Feb; 20(1):11. PubMed ID: 32013871 [TBL] [Abstract][Full Text] [Related]
6. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue. Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758 [No Abstract] [Full Text] [Related]
7. Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma. Liu P; Gu Q; Hu X; Tan X; Liu J; Xie A; Huang F J Xray Sci Technol; 2020; 28(6):1113-1121. PubMed ID: 33074215 [TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study. Li K; Yao Q; Xiao J; Li M; Yang J; Hou W; Du M; Chen K; Qu Y; Li L; Li J; Wang X; Luo H; Yang J; Zhang Z; Chen W Cancer Imaging; 2020 Jan; 20(1):12. PubMed ID: 32000852 [TBL] [Abstract][Full Text] [Related]
9. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging. Bowman AW; Bolan CW Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986 [TBL] [Abstract][Full Text] [Related]
11. CT and MRI of pancreatic tumors: an update in the era of radiomics. Bartoli M; Barat M; Dohan A; Gaujoux S; Coriat R; Hoeffel C; Cassinotto C; Chassagnon G; Soyer P Jpn J Radiol; 2020 Dec; 38(12):1111-1124. PubMed ID: 33085029 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls. Chu LC; Solmaz B; Park S; Kawamoto S; Yuille AL; Hruban RH; Fishman EK Abdom Radiol (NY); 2020 Aug; 45(8):2469-2475. PubMed ID: 32372206 [TBL] [Abstract][Full Text] [Related]
14. [Radiological evaluation of pancreatic ductal adenocarcinoma]. Akai H; Otomo K Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758 [TBL] [Abstract][Full Text] [Related]
15. Editorial for "Abbreviated Magnetic Resonance Imaging With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography: Assessment of Malignant Risks of Pancreatic Intraductal Papillary Mucinous Neoplasms". Shaikh S J Magn Reson Imaging; 2021 Oct; 54(4):1187-1188. PubMed ID: 33769636 [No Abstract] [Full Text] [Related]
16. Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case. Krishnasamy R; Agarwal S; Singh S; Puri S; Sakhuja P; Agarwal AK Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):553-6. PubMed ID: 17897923 [TBL] [Abstract][Full Text] [Related]
17. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging. Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935 [TBL] [Abstract][Full Text] [Related]
18. Resection of multiple invasive pancreatic ductal adenocarcinomas: A diagnostic dilemma distinguishing multicentric carcinogenesis from intrapancreatic metastasis. Ohike N; Norose T; Takano Y; Niiya F; Nagahama M; Matsuo K; Tanaka K; Furukawa T Pathol Int; 2020 Aug; 70(8):588-590. PubMed ID: 32515154 [No Abstract] [Full Text] [Related]
19. Differentiating hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma based on CT texture analysis. Wang Z; Chen X; Wang J; Cui W; Ren S; Wang Z Acta Radiol; 2020 May; 61(5):595-604. PubMed ID: 31522519 [No Abstract] [Full Text] [Related]
20. Efficacy of three-dimensional fast imaging with steady precession dynamic MR imaging in evaluating pancreatic ductal adenocarcinoma. Irie H; Honda H; Aibe H; Kuroiwa T; Yoshimitsu K; Shinozaki K; Yamaguchi K; Shimada M; Masuda K Clin Imaging; 2001; 25(1):50-6. PubMed ID: 11435041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]